SCHEMBL18026640

SCHEMBL18026640

CC(C)(C)CCN1CCN(C(=O)c2cccnc2)CC1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.61
▸ KDM4E B2RXH2 2/20 0.61
▸ ALOX15 P16050 1/20 0.61
▸ FABP6 P51161 1/20 0.60
▸ MAPK1 P28482 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.55
▸ PKM P14618 1/20 0.54
▸ HRH2 P25021 1/20 0.53
▸ HRH1 P35367 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ MEN1 O00255 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ DRD2 P14416 1/20 0.52
▸ DRD3 P35462 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18029395 0.85 KDM4E (0.65) ALDH1A1KDM4EALOX15FABP6MAPK1
SCHEMBL3323252 0.83 KDM4E (0.65) ALDH1A1KDM4EALOX15FABP6MAPK1
SCHEMBL31329773 0.82 FABP6 (0.67) ALDH1A1KDM4EALOX15FABP6MAPK1
SCHEMBL28121975 0.82 FABP6 (0.67) ALDH1A1KDM4EALOX15FABP6MAPK1
SCHEMBL9640623 0.82 HRH2 (0.70) ALDH1A1KDM4EALOX15FABP6MAPK1
SCHEMBL9763711 0.82 PKM (0.74) ALDH1A1KDM4EFABP6MAPK1SMN1; SMN2
SCHEMBL13152841 0.81 ALDH1A1 (0.62) ALDH1A1FABP6MAPK1TDP1PKM
SCHEMBL14067207 0.81 FABP6 (0.64) ALDH1A1KDM4EALOX15FABP6MAPK1
SCHEMBL31329800 0.81 MAPK1 (0.69) ALDH1A1KDM4EALOX15FABP6MAPK1
SCHEMBL12225719 0.81 MAPK1 (0.69) ALDH1A1KDM4EALOX15FABP6MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160244435-A1 EXPANDED THERAPEUTIC POTENTIAL IN NITROHETEROARYL ANTIMICROBIALS THE SCRIPPS RESEARCH INSTITUTE (US) 2016-08-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160244435-A1 EXPANDED THERAPEUTIC POTENTIAL IN NITROHETEROARYL ANTIMICROBIALS NQO1, TXN2, MPO ALDH1A1 1589/4885KDM4E 3910/4885ALOX15 1407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback